Welcome to Emmes, a full service clinical research organization (CRO) dedicated to supporting the advancement of human health and biopharmaceutical innovation through disciplined science, rigorous research, fact-based decision-making and operational excellence. Founded in 1977, Emmes possesses a broad range of therapeutic experience, with specialized expertise in infectious diseases, vaccines, ophthalmology, hematology/transplantation and gene/cell therapies.
Our longstanding strengths in bioinformatics and biostatistics help clients design studies and protocols that achieve study objectives. And because our experience resides at the intersection of the public and private healthcare sectors, we can help you develop regulatory strategies to maintain compliance, obtain fast-track status for rare disease therapies, and file regulatory submissions.
Emmes collaborates with commercial, government, non-profit, and academic institutions to design and manage insightful clinical studies that impact millions of patients worldwide. From our work with the National Institutes of Health on rare diseases, epidemics and pandemics to our ongoing relationships with biopharmaceutical companies and foundations, we are humbled by the contributions Emmes has made to organizations like yours.
Values drive us at Emmes; and as our name suggests, the quest for truth underscores everything we do. It guides the way we conduct research and the relationships we develop with clients. Through decades of experience we have learned that collaborative relationships thrive and human health benefits when truth is our compass.
We look forward to working with you.